4.5 Article

Pathology of Neurodegenerative Diseases

Journal

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a028035

Keywords

-

Categories

Funding

  1. National Institutes of Health [AG037491, NS084974, NS072187, AG016574, AG002132]
  2. Robert E. Jacoby Professorship
  3. Mangurian Foundation Lewy Body Dementia Program at Mayo Clinic
  4. CurePSP foundation
  5. Henry M. Jackson Foundation [HU0001-15-2-0020]
  6. Daiichi Sankyo Co., Ltd.

Ask authors/readers for more resources

Neurodegenerative disorders are characterized by progressive loss of selectively vulnerable populations of neurons, which contrasts with select static neuronal loss because of metabolic or toxic disorders. Neurodegenerative diseases can be classified according to primary clinical features (e. g., dementia, parkinsonism, or motor neuron disease), anatomic distribution of neurodegeneration (e. g., frontotemporal degenerations, extrapyramidal disorders, or spinocerebellar degenerations), or principal molecular abnormality. The most common neurodegenerative disorders are amyloidoses, tauopathies, alpha-synucleinopathies, and TDP-43 proteinopathies. The protein abnormalities in these disorders have abnormal conformational properties. Growing experimental evidence suggests that abnormal protein conformers may spread from cell to cell along anatomically connected pathways, which may in part explain the specific anatomical patterns observed at autopsy. In this review, we detail the human pathology of select neurodegenerative disorders, focusing on their main protein aggregates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available